 |
|
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Dae Won Jun
Clin Mol Hepatol. 2021;27(3):446-447. Published online 2021 May 21 DOI: https://doi.org/10.3350/cmh.2021.0133
|
|
Citations to this article as recorded by
 Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology.2023; 29(Suppl): S184. CrossRef Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef Risk factors in nonalcoholic fatty liver disease
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(Suppl): S79. CrossRef Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
Jung Hwan Yu, Han Ah Lee, Seung Up Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S136. CrossRef Advances in genetic variation in metabolism-related fatty liver disease
Fan Shi, Mei Zhao, Shudan Zheng, Lihong Zheng, Haiqiang Wang
Frontiers in Genetics.2023;[Epub] CrossRef
|